Literature DB >> 23307445

A study of meiotic segregation in a fertile human population following ovarian stimulation with recombinant FSH-LH.

Esther Velilla1, Silvia F Fernández, Jordi Suñol, Marisa López-Teijón.   

Abstract

OBJECTIVE: The aim of the study is to investigate the meiotic segregation in fresh eggs from anonymous egg donors and to analyze the baseline levels of aneuploidy in this population.
RESULTS: The study includes the largest series of donor eggs so far studied: 203 eggs from donors aged between 20 and 31 years. No diagnosis was obtained in 10.8 % of cases (22/ 203). The biopsy of the first and second polar bodies was completed in a sequential manner on day 0 and day 1 of embryo development. Chromosomes 13, 16, 18, 21 and 22 are analyzed by means of the FISH test. The diagnosable fertilized eggs gave an aneuploidy rate of 19.1 % (31/162), with 83.8 % (26/31) of the errors produced during meiosis I, 12.9 % (4/31) produced during meiosis II, and 3.2 % (1/31) produced during both meiosis I and II. The premature division of sister chromatids is the main source of meiotic error during Meiosis I, resulting in the creation of oocyte aneuploidy.
CONCLUSIONS: FISH analysis of the first and second polar body in donor oocytes gave an aneuploidy rate of 19.1 %. This study shows the majority of errors occur during Meiosis I.

Entities:  

Mesh:

Year:  2013        PMID: 23307445      PMCID: PMC3585680          DOI: 10.1007/s10815-012-9905-9

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  33 in total

1.  Prevention of age-related aneuploidies by polar body testing of oocytes.

Authors:  Y Verlinsky; J Cieslak; V Ivakhnenko; S Evsikov; G Wolf; M White; A Lifchez; B Kaplan; J Moise; J Valle; N Ginsberg; C Strom; A Kuliev
Journal:  J Assist Reprod Genet       Date:  1999-04       Impact factor: 3.412

Review 2.  Origin and mechanisms of non-disjunction in human autosomal trisomies.

Authors:  P Nicolaidis; M B Petersen
Journal:  Hum Reprod       Date:  1998-02       Impact factor: 6.918

Review 3.  Human aneuploidy: incidence, origin, and etiology.

Authors:  T Hassold; M Abruzzo; K Adkins; D Griffin; M Merrill; E Millie; D Saker; J Shen; M Zaragoza
Journal:  Environ Mol Mutagen       Date:  1996       Impact factor: 3.216

4.  Wide range of chromosome abnormalities in the embryos of young egg donors.

Authors:  S Munné; J Ary; C Zouves; T Escudero; F Barnes; C Cinioglu; B Ary; J Cohen
Journal:  Reprod Biomed Online       Date:  2006-03       Impact factor: 3.828

Review 5.  Effect of maternal age on the frequency of cytogenetic abnormalities in human oocytes.

Authors:  F Pellestor; T Anahory; S Hamamah
Journal:  Cytogenet Genome Res       Date:  2005       Impact factor: 1.636

6.  Karyotyping of human oocytes by cenM-FISH, a new 24-colour centromere-specific technique.

Authors:  C Gutiérrez-Mateo; J Benet; H Starke; M Oliver-Bonet; S Munné; T Liehr; J Navarro
Journal:  Hum Reprod       Date:  2005-08-26       Impact factor: 6.918

7.  Aneuploidy study of human oocytes first polar body comparative genomic hybridization and metaphase II fluorescence in situ hybridization analysis.

Authors:  C Gutiérrez-Mateo; J Benet; D Wells; P Colls; M G Bermúdez; J F Sánchez-García; J Egozcue; J Navarro; S Munné
Journal:  Hum Reprod       Date:  2004-11-01       Impact factor: 6.918

8.  Confocal microscopic analysis of the spindle and chromosome configurations of human oocytes matured in vitro.

Authors:  Yuan Li; Huai-Liang Feng; Yi-Juan Cao; Guang-Juan Zheng; Yong Yang; Steve Mullen; John K Critser; Zi-Jiang Chen
Journal:  Fertil Steril       Date:  2006-04       Impact factor: 7.329

9.  Chromosome anomalies in human oocytes in relation to age.

Authors:  R R Angell; J Xian; J Keith
Journal:  Hum Reprod       Date:  1993-07       Impact factor: 6.918

10.  First meiotic division abnormalities in human oocytes: mechanism of trisomy formation.

Authors:  R R Angell; J Xian; J Keith; W Ledger; D T Baird
Journal:  Cytogenet Cell Genet       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.